Alpa Laboratories reported a 24% decline in consolidated net profit for the financial year ended March 31, 2026, to ₹15.01 crore, down from ₹19.50 crore in the previous year. Revenue from operations for the period decreased to ₹105.81 crore compared to ₹112.45 crore in FY25. The standalone net profit for FY26 stood at ₹14.95 crore, a decrease from ₹19.68 crore in the prior year, with revenue from operations at ₹105.81 crore versus ₹111.64 crore.

For the quarter ended March 31, 2026, the company reported a consolidated net profit of ₹1.38 crore, a turnaround from the net loss of ₹2.12 crore recorded in the same period last year. Revenue from operations for the quarter stood at ₹31.40 crore. Standalone net profit for the quarter was ₹1.36 crore, compared to a net loss of ₹1.95 crore in the corresponding quarter of the previous year.

The Board of Directors approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, at a meeting held on May 29, 2026. Statutory auditors M/s C.H Padliya & Co. issued an audit report with an unmodified opinion on the financial results. The company operates in a single segment, Drugs & Chemicals.

The board appointed M/s S. S. Gandhi & Associates as the Internal Auditor and M/s. Sudeep Saxena & Associates as the Cost Auditor for the financial year 2026-27. The meeting commenced at 4:00 PM and concluded at 10:00 PM on May 29, 2026.

Financial Performance Summary

Alpa laboratories has announced a key management appointment, naming Ms. Yashoda Patidar as the company's new Company Secretary and Compliance Officer. The appointment was formalized during a Board of Directors meeting held on April 11, 2026, and takes effect immediately from the same date.

Board Approval and Regulatory Compliance

The appointment received approval from the Board of Directors based on recommendations from the Nomination and Remuneration Committee. The company has notified both the Bombay Stock Exchange and National Stock Exchange of India about this appointment in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Appointee Profile and Qualifications

Ms. Yashoda Patidar brings professional expertise to her new role as an Associate Member of the Institute of Company Secretaries of India. Her credentials include:

Key Appointment Details

The appointment follows standard corporate governance practices, with the company confirming that Ms. Patidar holds no shareholding in Alpa Laboratories Ltd. The disclosure indicates no relationship between the appointee and existing directors of the company.

Corporate Communication

The formal intimation was signed by Director Mahendra Singh Chawla (DIN: 00362058) and communicated to both stock exchanges where the company's shares are listed. This appointment strengthens the company's compliance framework and corporate governance structure as Ms. Patidar assumes responsibility for ensuring adherence to regulatory requirements and secretarial functions.